Skip to content
2000
Volume 18, Issue 1
  • ISSN: 1574-888X
  • E-ISSN: 2212-3946

Abstract

Stress urinary incontinence (SUI) is a common urinary system disease worldwide. Nowadays, medical therapy and surgery can control the symptoms and improve the life quality of patients. However, they might also bring about complications as the standard therapy fails to address the underlying problem of urethral sphincter dysfunction. Recent advances in cell technology have aroused interest in the use of autologous stem cell therapy to restore the ability of urinary control. The present study reviewed several types of stem cells for the treatment of SUI in the experimental and clinical stages.

Loading

Article metrics loading...

/content/journals/cscr/10.2174/1574888X17666220304213057
2023-01-01
2024-11-23
Loading full text...

Full text loading...

/content/journals/cscr/10.2174/1574888X17666220304213057
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test